-
Product Insights
Frontotemporal Dementia (FTD) – Drugs In Development, 2023
Global Markets Direct’s, ‘Frontotemporal Dementia (FTD) - Drugs In Development, 2023’, provides an overview of the Frontotemporal Dementia (FTD) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Frontotemporal Dementia (FTD), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Sector Analysis
Neuromodulation Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Neuromodulation Devices Market Report Overview The neuromodulation devices market size was valued at $6.06 billion in 2023. Factors such as deep brain stimulation and spinal cord stimulation will drive the market growth at a CAGR of more than 6% from 2023 to 2033. Neuromodulation is one of the fastest-growing medical device markets. Within the last 10 years, the market has grown exponentially, with spinal cord stimulation being the largest market. Neuromodulation Devices Market Outlook 2023-2033 ($ Billion) Buy Full Report...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TSHA-120 in Neuropathy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TSHA-120 in Neuropathy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.TSHA-120 in Neuropathy Drug Details:TSHA-120 is under development for the treatment of giant axonal...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VGL-101 in Neurodegenerative Diseases
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. VGL-101 in Neurodegenerative Diseases Drug Details: VGL-101 is under development for the treatment of adult-onset...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AXER-204 in Chronic Spinal Cord Injury
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AXER-204 in Chronic Spinal Cord Injury report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.AXER-204 in Chronic Spinal Cord InjuryDrug Details:AXER-204 is under development for...
-
Sector Analysis
Middle East and Africa (MEA) Mobile Broadband Market Trends and Opportunities, 2023 Update
MEA Mobile Broadband Market Trends and Opportunities Report Overview The total mobile service revenue in MEA is estimated at $93.9 billion in 2023. The market in the MEA region is expected to grow at a CAGR of more than 3% during 2023-2028. The market will be driven by growth in all the device categories over the period. Handsets will be the dominant device category. MEA Mobile Broadband Market Outlook 2023-2028 ($ Billion) Buy the Full Report or Download a Free...
-
Product Insights
Axon Field
Axon Field is a producing field located in Tamaulipas, Mexico. It is being operated by Petroleos Mexicanos. Empower your strategies with our Axon Field report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy...
-
Company Insights
Aegon – Digital Transformation Strategies
Aegon Digital Transformation Strategies Report Overview Aegon has been focusing on data-led innovation as a part of its digital transformation strategies. The annual ICT spending of Aegon was estimated at $2.4 billion in 2022. A major share of this spending is earmarked for acquiring software, hardware, and ICT services from vendors. Aegon is a provider of pension plans, life insurance, and asset management services to individuals and families, pension funds, companies, and other institutions. Total ICT Spending 2022 $2.4 billion...
-
Product Insights
United States Neuromodulation Devices Market Share
Neuromodulation Devices (Neurology Devices) United States Market Share report provides quantitative market trends within the Neurology Devices therapeutic area. Robust methodologies ensure an accurate overview of the market to deliver a comprehensive and precise market analysis. It incorporates primary sources from both the demand and supply sides. This is an on-demand report that will be delivered upon request. The report will be delivered within 1 business day of the purchase, excluding weekends and holidays. Certain sections of the report may...
-
Product Insights
Ak Star/ Kuala Lumpur City – Axon Bukit Bintang Residence – Kuala Lumpur
Equip yourself with the essential tools needed to make informed and profitable decisions with our Ak Star/ Kuala Lumpur City - Axon Bukit Bintang Residence - Kuala Lumpur report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full...